Cytokinetics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -43.9% | -87.5% | -26.5% | +102.4% | -100.3% | – | +18.0% | +71.2% | -11.9% | -9.7% | -15.7% | -15.2% | -13.9% | -26.6% | -6.1% | +1,060.3% | -83.9% | -2.6% | -56.6% | +91.2% | +922.6% | -97.9% | +7,649.8% | -97.2% | -22.2% | +135.7% | -81.2% | -56.4% | +342.3% | -50.1% | -70.2% | +85.9% | +3,555.9% | -90.7% | +4,128.6% | -97.1% | +817.1% | +9.0% | +64.9% | – | |
| – | +20.4% | -17.1% | +2.7% | +25.9% | +5.2% | -15.7% | -2.5% | -0.9% | +8.8% | +1.2% | +2.0% | -15.8% | -9.4% | +18.6% | +0.2% | +11.1% | +20.7% | +8.0% | +15.5% | +32.9% | -10.2% | +5.6% | +24.4% | +9.8% | +19.6% | +5.9% | +4.8% | -0.8% | +3.0% | -4.0% | -2.4% | +6.3% | +10.7% | +6.6% | -97.7% | +17.2% | +6.8% | -16.4% | +14.2% | – | |
| – | -75.2% | -253.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -228.7% | – | – | – | – | -470.1% | – | -289.1% | – | – | – | – | – | – | – | – | – | – | – | -101.2% | – | +13.9% | +72.0% | – | |
| – | -2.9% | +2.7% | +2.7% | +25.9% | +5.2% | -15.7% | -2.5% | -0.9% | +8.8% | +1.2% | +2.0% | -15.8% | -9.4% | +18.6% | +0.2% | +11.1% | +20.7% | +8.0% | +15.5% | +32.9% | -10.2% | +5.6% | +24.4% | +9.8% | +19.6% | +5.9% | +4.8% | -0.8% | +3.0% | -4.0% | -2.4% | +6.3% | +10.7% | +6.6% | +12.7% | -11.8% | +2.3% | -5.9% | +2.4% | – | |
| – | -7.5% | +21.6% | +4.0% | +14.4% | +6.2% | -9.7% | -13.1% | -11.0% | +5.5% | +24.9% | +4.2% | -0.8% | +8.5% | +17.6% | +13.8% | -13.1% | +13.1% | +12.2% | +35.9% | +23.6% | +29.0% | -2.2% | +29.2% | +12.9% | +11.9% | -8.0% | -20.0% | +1.0% | +10.0% | +3.1% | +11.7% | +11.5% | +10.0% | -8.0% | +14.6% | +5.7% | +32.1% | +14.4% | -0.5% | – | |
| – | -69.9% | +273.3% | +4.0% | +14.4% | +6.2% | -9.7% | -13.1% | -11.0% | +5.5% | +24.9% | +4.2% | -0.8% | +8.5% | +17.6% | +13.8% | -13.1% | +13.1% | +12.2% | +35.9% | +23.6% | +29.0% | -2.2% | +29.2% | +12.9% | +11.9% | -8.0% | -20.0% | +1.0% | +10.0% | +3.1% | +11.7% | +11.5% | +10.0% | -8.0% | +206.8% | -5.7% | +16.4% | +3.8% | +2.2% | – | |
| – | -76.3% | -402.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -802.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.2% | +266.9% | +48.6% | +1.2% | +20.3% | +5.5% | +4.9% | +3.6% | +8.9% | +1.3% | +7.5% | +3.5% | +24.0% | +15.9% | +2.3% | -3.7% | +2.5% | -29.8% | +2.4% | +2.5% | +24.6% | +5.0% | +5.4% | +60.7% | +3.2% | -18.6% | +1.0% | +4.7% | +21.9% | +1.5% | +40.3% | -8.2% | +1.3% | +1.6% | +5.7% | +8.5% | +15.2% | +9.9% | +4.5% | – | |
| – | -77.6% | -461.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +3.7% | +200.6% | +107.7% | +15.6% | -6.5% | -33.0% | -10.5% | +94.4% | -45.6% | +33.6% | -43.9% | +209.0% | -82.7% | -35.5% | -223.5% | – | +36.5% | -22.8% | +278.6% | -117.5% | – | – | +3.3% | -73.1% | +23.8% | – | – | – | – | – | – | – | – | – | – | |
| – | -77.6% | -461.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -90.0% | -756.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -690.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.